COVID-19 Promotes Pulmonary Tumor Growth via Hypoxia and VEGF-Driven Angiogenesis

This study investigates how SARS-CoV-2 infection triggers pulmonary tumor outgrowth by inducing hypoxia and inflammation, which activate VEGF-dependent angiogenesis. The research provides experimental evidence that COVID-19 creates a microenvironment conducive to tumor growth by upregulating vascular endothelial growth factors in lung tissue. These findings highlight a potential mechanism linking COVID-19 infection to the progression of dormant pulmonary cancers.

Originally published by gnews